一硝酸イソソルビド錠剤の世界市場レポート (2025年)

一硝酸イソソルビド錠剤の市場規模は、今後数年間で力強い成長が見込まれます。2029年には15億1,000万米ドルに成長し、CAGRは5.6%となります。予測期間の成長は、規制当局の承認や特許の失効、ジェネリック医薬品の採用拡大、生活習慣に関連する危険因子の増加、心血管疾患管理に対する政府の取り組み、診断インフラの改善、啓発キャンペーンなどに起因すると考えられます。この期間の主な動向には、徐放性製剤の進歩、技術革新、デジタルヘルスプラットフォームとeコマースの台頭、デジタルヘルス技術の統合、一硝酸イソソルビドと他の心血管治療薬との併用などがあります。

心血管疾患（CVD）の有病率の増加が一硝酸イソソルビド錠剤市場の成長を牽引しています。冠動脈疾患、心不全、高血圧などのCVDは、飽和脂肪酸、トランス脂肪酸、ナトリウム、加糖などを多く含む不健康な食生活などの要因で蔓延しつつあり、肥満、高血圧、高コレステロールなどの症状の一因となっています。一硝酸イソソルビド錠剤は、血管を弛緩させ広げることにより血流を改善し、心臓の仕事量を減らし、胸痛（狭心症）を緩和することにより、これらの疾患を管理するために一般的に使用されています。2023年12月のオーストラリア保健福祉研究所の報告によると、オーストラリアにおける冠動脈性心疾患（CHD）の死亡者数は増加傾向にあり、2021年の死亡者数は1万4,100人、2022年には1万4,900人と増加しています。このような心血管疾患の有病率の増加は、一硝酸イソソルビド錠剤のような効果的な治療に対する需要に大きく寄与しています。

オンライン薬局の普及が、一硝酸イソソルビド錠剤市場の成長をさらに後押ししています。消費者は、物理的な薬局に出向く必要なく、より便利で手頃な価格で薬を入手できることを求めています。オンライン薬局は、特に心血管疾患などの慢性疾患を管理する患者にとって、宅配、競合価格、利用しやすい環境を提供しています。Alliance for Safe Online Pharmacies（ASOP）が2023年9月に実施した調査によると、18歳以上のアメリカ人の52%がオンライン薬局を利用したことがあり、以前より顕著に増加していることが明らかになりました。このようなオンライン薬局の利用急増により、患者は一硝酸イソソルビド錠剤を含む必須医薬品へのアクセスが容易になり、市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の一硝酸イソソルビド錠剤市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の一硝酸イソソルビド錠剤市場：成長率分析
• 世界の一硝酸イソソルビド錠剤の市場規模・成長率：実績値、2019～2024年
• 世界の一硝酸イソソルビド錠剤の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の一硝酸イソソルビド錠剤市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の一硝酸イソソルビド錠剤市場：剤形別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 即効剤
• 徐放剤
• 世界の一硝酸イソソルビド錠剤市場：適応症別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 狭心症
• 心不全
• 高血圧
• 世界の一硝酸イソソルビド錠剤市場：流通チャネル別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の一硝酸イソソルビド錠剤市場：即効剤の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 低用量
• シングルストレングスタブレット
• 他の薬との併用
• 世界の一硝酸イソソルビド錠剤市場：徐放剤の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 中用量
• 高用量
• 1日1回服用処方
• 1日2回服用処方

第7章 地域別・国別の分析

• 世界の一硝酸イソソルビド錠剤市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の一硝酸イソソルビド錠剤市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 一硝酸イソソルビド錠剤市場：競合情勢
• 一硝酸イソソルビド錠剤市場：企業プロファイル
  • Pfizer Inc.（概要、製品・サービス、戦略、財務分析）
  • Merck & Co. Inc.（概要、製品・サービス、戦略、財務分析）
  • AstraZeneca PLC（概要、製品・サービス、戦略、財務分析）
  • Abbott Laboratories Inc.（概要、製品・サービス、戦略、財務分析）
  • Teva Pharmaceutical Industries Ltd.（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.
• Cipla Ltd.
• Zydus Lifesciences Limited
• Recipeharm
• Torrent Pharmaceuticals Ltd.
• Micro Labs Ltd.
• Lotus Pharmaceuticals
• Healthy Inc.
• Qilu Pharmaceutical Co., Ltd
• Lunan Pharmaceutical Group
• Johnlee Pharmaceuticals Pvt. Ltd.
• Niksan Pharmaceutical
• Shandong Keyuan Pharmaceutical
• Prevego Healthcare & Research Private Limited

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 一硝酸イソソルビド錠剤市場：最新機会を提供する国（2029年）
• 一硝酸イソソルビド錠剤市場：最新機会を提供する部門（2029年）
• 一硝酸イソソルビド錠剤市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Isosorbide mononitrate tablets are long-acting nitrate medications primarily used to prevent and control chest pain (angina) associated with coronary artery disease. The medication works by relaxing and dilating blood vessels, particularly in the heart, which allows for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function.

The main dosage forms of isosorbide mononitrate tablets are immediate-release tablets and extended-release tablets. Immediate-release tablets are designed to dissolve quickly, allowing for rapid absorption and fast relief, especially for conditions such as angina. These tablets are used for various indications, including angina pectoris, heart failure, and hypertension, and are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The isosorbide mononitrate tablet market research report is one of a series of new reports from The Business Research Company that provides isosorbide mononitrate tablet market statistics, including the isosorbide mononitrate tablet industry global market size, regional shares, competitors with the isosorbide mononitrate tablet market share, detailed isosorbide mononitrate tablet market segments, market trends, and opportunities, and any further data you may need to thrive in the isosorbide mononitrate tablet industry. This isosorbide mononitrate tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The isosorbide mononitrate tablet market size has grown strongly in recent years. It will grow from$1.14 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the growing elderly population, the increasing incidence of heart-related conditions, greater awareness of heart health, the availability of generic drugs, and public health campaigns.

The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to$1.51 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to regulatory approvals and patent expirations, the increasing adoption of generic drugs, growth in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and awareness campaigns. Key trends during this period include advancements in extended-release formulations, technological innovations, the rise of digital health platforms and e-commerce, integration of digital health technologies, and the combination of isosorbide mononitrate with other cardiovascular drugs.

The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the isosorbide mononitrate tablet market. CVDs, including coronary artery disease, heart failure, and hypertension, are becoming more widespread due to factors such as unhealthy diets high in saturated fats, trans fats, sodium, and added sugars, which contribute to conditions such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets are commonly used to manage these diseases by relaxing and widening blood vessels, which improves blood flow, reduces the heart's workload, and alleviates chest pain (angina). According to a report from the Australian Institute of Health and Welfare in December 2023, coronary heart disease (CHD) deaths in Australia have been increasing, with 14,100 deaths in 2021 rising to 14,900 in 2022. This growing prevalence of cardiovascular diseases is significantly contributing to the demand for effective treatments, such as isosorbide mononitrate tablets.

The increasing adoption of online pharmacies is further propelling the growth of the isosorbide mononitrate tablet market. Consumers are seeking greater convenience, affordability, and accessibility to medications without the need to visit physical pharmacies. Online pharmacies offer home delivery, competitive pricing, and improved availability, particularly for patients managing chronic conditions such as cardiovascular diseases. A survey conducted by the Alliance for Safe Online Pharmacies (ASOP) in September 2023 revealed that 52% of Americans aged 18 and older had used an online pharmacy, showing a notable increase from previous years. This surge in online pharmacy usage is making it easier for patients to access essential medications, including isosorbide mononitrate tablets, fueling market growth.

Pharmaceutical companies are focusing on the development of extended-release (ER) formulations of isosorbide mononitrate to improve patient compliance and enhance treatment outcomes. ER tablets provide sustained therapeutic effects by gradually releasing the medication over an extended period, reducing the need for frequent dosing and ensuring consistent blood levels of the drug. In February 2024, Zydus Lifesciences Limited received approval from the U.S. Food and Drug Administration (FDA) to market isosorbide mononitrate extended-release tablets in strengths of 30 mg, 60 mg, and 120 mg. These tablets help prevent chest pain (angina) in patients with coronary artery disease and offer a more convenient treatment option for those requiring long-term management, further contributing to the growth of the isosorbide mononitrate tablet market.

Major players in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co. Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, and Prevego Healthcare & Research Private Limited.

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in isosorbide mononitrate tablet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the isosorbide mononitrate tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The isosorbide mononitrate tablet market consists of sales of dilatrate-SR, isochron, monoket, and imdur, pediatric and geriatric-adjusted tablets, and combination products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isosorbide Mononitrate Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isosorbide mononitrate tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isosorbide mononitrate tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isosorbide mononitrate tablet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Immediate-Release Tablets; Extended-Release Tablets
• 2) By Indication Type: Angina Pectoris; Heart Failure; Hypertension
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Immediate-Release Tablets: Low-Dose; Single Strength Tablets; Combination With Other Drugs
• 2) By Extended-Release Tablets: Moderate-Dose; High-Dose; Once-Daily Formulation; Twice-Daily Formulation
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AstraZeneca PLC; Abbott Laboratories Inc.; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isosorbide Mononitrate Tablet Market Characteristics

3. Isosorbide Mononitrate Tablet Market Trends And Strategies

4. Isosorbide Mononitrate Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Isosorbide Mononitrate Tablet Growth Analysis And Strategic Analysis Framework

• 5.1. Global Isosorbide Mononitrate Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Isosorbide Mononitrate Tablet Market Growth Rate Analysis
• 5.4. Global Isosorbide Mononitrate Tablet Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Isosorbide Mononitrate Tablet Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Isosorbide Mononitrate Tablet Total Addressable Market (TAM)

6. Isosorbide Mononitrate Tablet Market Segmentation

• 6.1. Global Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• 6.2. Global Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Angina Pectoris
• Heart Failure
• Hypertension
• 6.3. Global Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose
• Single Strength Tablets
• Combination With Other Drugs
• 6.5. Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Moderate-Dose
• High-Dose
• Once-Daily Formulation
• Twice-Daily Formulation

7. Isosorbide Mononitrate Tablet Market Regional And Country Analysis

• 7.1. Global Isosorbide Mononitrate Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Isosorbide Mononitrate Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isosorbide Mononitrate Tablet Market

• 8.1. Asia-Pacific Isosorbide Mononitrate Tablet Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isosorbide Mononitrate Tablet Market

• 9.1. China Isosorbide Mononitrate Tablet Market Overview
• 9.2. China Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isosorbide Mononitrate Tablet Market

• 10.1. India Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isosorbide Mononitrate Tablet Market

• 11.1. Japan Isosorbide Mononitrate Tablet Market Overview
• 11.2. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isosorbide Mononitrate Tablet Market

• 12.1. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isosorbide Mononitrate Tablet Market

• 13.1. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isosorbide Mononitrate Tablet Market

• 14.1. South Korea Isosorbide Mononitrate Tablet Market Overview
• 14.2. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isosorbide Mononitrate Tablet Market

• 15.1. Western Europe Isosorbide Mononitrate Tablet Market Overview
• 15.2. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isosorbide Mononitrate Tablet Market

• 16.1. UK Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isosorbide Mononitrate Tablet Market

• 17.1. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isosorbide Mononitrate Tablet Market

• 18.1. France Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isosorbide Mononitrate Tablet Market

• 19.1. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isosorbide Mononitrate Tablet Market

• 20.1. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isosorbide Mononitrate Tablet Market

• 21.1. Eastern Europe Isosorbide Mononitrate Tablet Market Overview
• 21.2. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isosorbide Mononitrate Tablet Market

• 22.1. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isosorbide Mononitrate Tablet Market

• 23.1. North America Isosorbide Mononitrate Tablet Market Overview
• 23.2. North America Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isosorbide Mononitrate Tablet Market

• 24.1. USA Isosorbide Mononitrate Tablet Market Overview
• 24.2. USA Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isosorbide Mononitrate Tablet Market

• 25.1. Canada Isosorbide Mononitrate Tablet Market Overview
• 25.2. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isosorbide Mononitrate Tablet Market

• 26.1. South America Isosorbide Mononitrate Tablet Market Overview
• 26.2. South America Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isosorbide Mononitrate Tablet Market

• 27.1. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isosorbide Mononitrate Tablet Market

• 28.1. Middle East Isosorbide Mononitrate Tablet Market Overview
• 28.2. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isosorbide Mononitrate Tablet Market

• 29.1. Africa Isosorbide Mononitrate Tablet Market Overview
• 29.2. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isosorbide Mononitrate Tablet Market Competitive Landscape And Company Profiles

• 30.1. Isosorbide Mononitrate Tablet Market Competitive Landscape
• 30.2. Isosorbide Mononitrate Tablet Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Isosorbide Mononitrate Tablet Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd.
• 31.2. Aurobindo Pharma Ltd.
• 31.3. Cipla Ltd.
• 31.4. Zydus Lifesciences Limited
• 31.5. Recipeharm
• 31.6. Torrent Pharmaceuticals Ltd.
• 31.7. Micro Labs Ltd.
• 31.8. Lotus Pharmaceuticals
• 31.9. Healthy Inc.
• 31.10. Qilu Pharmaceutical Co., Ltd
• 31.11. Lunan Pharmaceutical Group
• 31.12. Johnlee Pharmaceuticals Pvt. Ltd.
• 31.13. Niksan Pharmaceutical
• 31.14. Shandong Keyuan Pharmaceutical
• 31.15. Prevego Healthcare & Research Private Limited

32. Global Isosorbide Mononitrate Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isosorbide Mononitrate Tablet Market

34. Recent Developments In The Isosorbide Mononitrate Tablet Market

35. Isosorbide Mononitrate Tablet Market High Potential Countries, Segments and Strategies

• 35.1 Isosorbide Mononitrate Tablet Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Isosorbide Mononitrate Tablet Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Isosorbide Mononitrate Tablet Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer